FOR IMMEDIATE RELEASE
ABORTION BUSINESS SOLD FETAL BODY PARTS FOR $765 EACH TO TAXPAYER-FUNDED LABS, NEW RECORDS SHOW
Cercle Allocation Services, Inc. Charged University of California $765 Per Body Part Harvested From Late-Term Abortion Clinics
Contact: David Daleiden, media@centerformedicalprogress.org, 949.734.0859
IRVINE, Sept. 30—New documents released under a California Public Records Act request show a new abortion side business, Cercle Allocation Services, Inc., selling fetal body parts for $765 each to taxpayer-funded laboratories at the University of California.
Cercle Allocation Services is the fetal organ harvesting company that took possession of an infant believed to have been born alive at a late-term abortion clinic in New Jersey two years ago, based on expert analysis of medical records in the recent investigative documentary “What Happened To Clementine?” by The Center for Medical Progress, who made the public records request.
The new documents include purchase orders from a UCLA laboratory to Cercle in August and September of 2023, for a total of $16,065 for 21 fetal body parts—14 livers and 7 thymus glands. The purchase orders show each individual organ being billed at a separate $765 price.
The purchase orders were apparently revised multiple times by UCLA at Cercle’s demand, to remove sales tax from the orders so it would look like only “services”, rather than “items”, were being sold. In a September 2023 email, Cercle’s Account Manager told UCLA, “The overriding issue is the use of terminology that we must not use due to their improper implication that we are selling taxable items,” and, “Due to the nature of our business we must be very careful and clear that we invoice fees for our procurement services (untaxable).” The Account Manager wrote that “notations of ‘Total Tax’ and ‘Total Price Includes Sales Tax’ would imply that we are selling the items received (which are illegal to sell). Therefore, it is quite important that Purchase Orders are created to authorize payment for our Services, which can be tied to the sample dates and numbers”. The purchase orders show that Cercle billed UCLA for as many as five $765-per-body-part charges in a single day.
42 U.S. Code 289g-2 makes it a federal felony to “transfer” “any human fetal tissue” for “valuable consideration”.
Recently published studies note that Cercle was previously doing business as Advanced Bioscience Resources, a fetal organ harvesting company that maintained extensive government contracts. ABR, along with its longtime business partners at Planned Parenthood, was the subject of Congressional criminal referrals in 2016 after investigations prompted by CMP’s undercover video reporting. Planned Parenthood has supplied aborted fetuses to ABR/Cercle since the 1990s.
CMP previously released undercover video interviews with ABR admitting that sometimes aborted fetuses “just fell out” of patients in the operating room. ABR’s procurement manager Perrin Larton—now with Cercle—testified under oath in 2019 that intact fetuses were harvested “every couple months”, and that sometimes she saw fetal hearts beating after being cut out. ABR has sold FDA-regulated “current Good Tissue Practice” (cGTP) fetal organs for up to $7,000 each to taxpayer-funded laboratories.
The new public records documents from UCLA also show that in March 2025, Cercle had to cancel an order for fetal brain because it was unable to procure it. The medical records reviewed in CMP’s documentary “What Happened To Clementine?” show Cercle’s research procurement site in New Jersey, the Cherry Hill Women’s Center, using large doses of the labor-inducing drug Misoprostol on abortion patients. According to expert analysis, the time intervals and procedure steps recorded after that point leave barely one minute for the 5-month-gestation infant, named Clementine by her parents, to be taken out of her mother in the operating room.
“These new records from Cercle’s abortion side business harvesting baby body parts show the extreme financial incentives that exist for ‘research’ abortions to deliver whole, preemie-size babies alive—as appears to have been done to baby Clementine and her mother, and potentially thousands of others,” notes David Daleiden, founder and president of CMP.
Elise Ketch, associate reporter with CMP, states, “Mass organ harvesting for fetal research is the beating heart of the abortion industry. Behind all the fiercest defenders of abortion you can find a tie to profits from this black market. You just have to look.”
Thomas Kearns, the father of baby Clementine from the documentary and founder of the Clementine’s Voice advocacy group, says, “Looking at the prices on this page reminds me of what they claim my daughter Clementine’s life was worth. I’m reminded that these body parts came from children just like my daughter Clementine—children who were more than just a liver or a thymus. The value that Clementine and these children had to offer the world was not a price tag from a business exchange. They are not just their body parts or organs. They had souls, they had families, they had their own lives if they were not interrupted by the abortion and organ harvesting industry. This is the same agency that took my daughter two years ago. Were the babies in these purchase orders harvested with the same partial-birth abortion methods as my daughter?”
###
Watch CMP’s update video about the new records here: https://www.youtube.com/watch?v=3PntNuwhdUc
Learn more about CMP’s investigative reporting at www.centerformedicalprogress.org
